Odonicin is primarily used in the field of microbiology and infectious disease treatment due to its antimicrobial properties. It shows activity against certain Gram-positive bacteria, making it useful in research settings for studying bacterial resistance and mode of action of antibiotics. Odonicin has also been investigated for its potential antifungal effects, particularly against yeast strains such as Candida species. Its application remains mostly experimental, serving as a reference compound in laboratory studies aimed at developing new anti-infective agents. Due to its specific spectrum and mechanism, it is not widely used in clinical medicine but supports the design and testing of novel therapeutic molecules.